ΚΟΡΩΝΟΪΟΣ (SARS-CoV-2) / ΕΙΔΙΚΟΣ ΧΕΙΡΙΣΜΟΣ ΑΙΜΑΤΟΛΟΓΙΚΩΝ ΑΣΘΕΝΩΝ
Μαρτίου 24, 2020
CORONAVIRUS DISEASE COVID-19: EBMT RECOMMENDATIONS UPDATE MARCH 30, 2020
Απριλίου 2, 2020
Recommendations for hematologists in COVID-19 crisis COVID-19, caused by SARS-CoV-2, is expected to be a devastating infection in patients with active cancer. It should be taken seriously and managed rigorously without jeopardizing the curative chance of individual cancer patients. In view of the rapidly changing evidence and general situation the EHA Scientific Working Group Infections in Hematology has developed key questions and answers on the management of cancer patients with or at risk of COVID-19
